share_log

Cracking The Code: Understanding Analyst Reviews For Tandem Diabetes Care

Benzinga ·  Apr 23 15:01

Ratings for Tandem Diabetes Care (NASDAQ:TNDM) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings20300
Last 30D10000
1M Ago10100
2M Ago00100
3M Ago00100

The 12-month price targets, analyzed by analysts, offer insights with an average target of $34.0, a high estimate of $40.00, and a low estimate of $24.00. This current average has increased by 26.87% from the previous average price target of $26.80.

price target chart

Breaking Down Analyst Ratings: A Detailed Examination

The standing of Tandem Diabetes Care among financial...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment